Skip to main content
NCBI home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2012 Oct 29;30:43–48. doi: 10.1016/S0213-005X(12)70104-0

Influenza A(H1N1)pdm09-related pneumonia and other complications

Neumonía relacionada con la gripe A(H1N1)pdm09 y otras complicaciones

Diego Viasus a, José A Oteo Revuelta b, Joaquín Martínez-Montauti c, Jordi Carratalà a,⁎
PMCID: PMC7130364  PMID: 23116792

Abstract

Influenza A(H1N1)pdm09 virus infection was associated with significant morbidity, mainly among children and young adults. The majority of patients had self-limited mild-to-moderate uncomplicated disease. However, some patients developed severe illness and some died. In addition to respiratory complications, several complications due to direct and indirect effects on other body systems were associated with influenza A(H1N1)pdm09 virus infection. The main complications reported in hospitalized adults with influenza A(H1N1)pdm09 were pneumonia (primary influenza pneumonia and concomitant/secondary bacterial pneumonia), exacerbations of chronic pulmonary diseases (mainly chronic obstructive pulmonary disease and asthma), the need for intensive unit care admission (including mechanical ventilation, acute respiratory distress syndrome and septic shock), nosocomial infections and acute cardiac events. In experimentally infected animals, the level of pulmonary replication of the influenza A(H1N1)pdm09 virus was higher than that of seasonal influenza viruses. Pathological studies in autopsy specimens indicated that the influenza A(H1N1)pdm09 virus mainly targeted the lower respiratory tract, resulting in diffuse alveolar damage (edema, hyaline membranes, inflammation, and fibrosis), manifested clinically by severe acute respiratory distress syndrome with refractory hypoxemia. Influenza A(H1N1)pdm09-related pneumonia and other complications were associated with increased morbidity and mortality among hospitalized patients.

Keywords: Influenza A(H1N1)pdm09 virus, Complication, Pneumonia, Intensive care unit, Mortality

References

  • 1.Pérez-Padilla R., De la Rosa-Zamboni D., Ponce de León S., Hernández M., Quiñones-Falconi F., Bautista E., INER Working Group on Influenza Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med. 2009;361:680–689. doi: 10.1056/NEJMoa0904252. [DOI] [PubMed] [Google Scholar]
  • 2.Surveillance Group for New Influenza A(H1N1) Virus Investigation and Control in Spain New influenza A(H1N1) virus infections in Spain, April-May 2009. Euro Surveill. 2009;14:19209. doi: 10.2807/ese.14.19.19209-en. [DOI] [PubMed] [Google Scholar]
  • 3.Viasus D., Cordero E., Rodríguez-Baño J., Oteo J.A., Fernández-Navarro A., Ortega L., Novel Influenza A (H1N1) Study Group of the Spanish Network for Research in Infectious Diseases (REIPI) Changes in epidemiology, clinical features and severity of influenza A (H1N1) 2009 pneumonia in the first post-pandemic influenza season. Clin Microbiol Infect. 2012;18:E55–E62. doi: 10.1111/j.1469-0691.2011.03753.x. [DOI] [PubMed] [Google Scholar]
  • 4.Athanasiou M., Baka A., Andreopoulou A., Spala G., Karageorgou K., Kostopoulos L. Influenza surveillance during the post-pandemic influenza 2010/11 season in Greece, 04 October 2010 to 22 May 2011. Euro Surveill. 2011;16:20004. [PubMed] [Google Scholar]
  • 5.Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza. Bautista E., Chotpitayasunondh T., Gao Z., Harper S.A., M. Shaw, Uyeki T.M., Zaki S.R. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med. 2010;362:1708–1719. doi: 10.1056/NEJMra1000449. [DOI] [PubMed] [Google Scholar]
  • 6.Rothberg M.B., Haessler S.D., Brown R.B. Complications of viral influenza. Am J Med. 2008;121:258–264. doi: 10.1016/j.amjmed.2007.10.040. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Itoh Y., Shinya K., Kiso M., Watanabe T., Sakoda Y., Hatta M. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature. 2009;460:1021–1025. doi: 10.1038/nature08260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Viasus D., Paño-Pardo J.R., Pachón J., Riera M., López-Medrano F., Payeras A., Novel Influenza A(H1N1) Study Group of the Spanish Network for Research in Infectious Diseases (REIPI) Pneumonia complicating pandemic (H1N1) 2009: risk factors, clinical features, and outcomes. Medicine (Baltimore) 2011;90:328–336. doi: 10.1097/MD.0b013e31822e67a7. [DOI] [PubMed] [Google Scholar]
  • 9.Jain S., Benoit S.R., Skarbinski J., Bramley A.M., Finelli L. for the 2009 Pandemic Influenza A (H1N1) Virus Hospitalizations Investigation Team. Influenza-Associated Pneumonia Among Hospitalized Patients With 2009 Pandemic Influenza A (H1N1) Virus—United States, 2009. Clin Infect Dis. 2012;54:1221–1229. doi: 10.1093/cid/cis197. [DOI] [PubMed] [Google Scholar]
  • 10.Cullen G., Martin J., O’Donnell J., Boland M., Canny M., Keane E. Surveillance of the first 205 confirmed hospitalised cases of pandemic H1N1 influenza in Ireland, 28 April - 3 October 2009. Euro Surveill. 2009;14:19389. [PubMed] [Google Scholar]
  • 11.Jain S., Kamimoto L., Bramley A.M., Schmitz A.M., Benoit S.R., Louie J. 2009 Pandemic Influenza A (H1N1) Virus Hospitalizations Investigation Team. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med. 2009;361:1935–1944. doi: 10.1056/NEJMoa0906695. [DOI] [PubMed] [Google Scholar]
  • 12.Louie J.K., Acosta M., Winter K., Jean C., Gavali S., Schechter R., California Pandemic (H1N1) Working Group Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA. 2009;302:1896–1902. doi: 10.1001/jama.2009.1583. [DOI] [PubMed] [Google Scholar]
  • 13.Shieh W.J., Blau D.M., Denison A.M., Deleon-Carnes M., Adem P., Bhatnagar J. 2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States. Am J Pathol. 2010;177:166–175. doi: 10.2353/ajpath.2010.100115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Nin N., Sánchez-Rodríguez C., Ver L.S., Cardinal P., Ferruelo A., Soto L. Lung histopathological findings in fatal pandemic influenza A (H1N1) Med Intensiva. 2012;36:24–31. doi: 10.1016/j.medin.2011.10.005. [DOI] [PubMed] [Google Scholar]
  • 15.ANZIC Influenza Investigators Critical care services and. 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med. 2009;361:1925–1934. doi: 10.1056/NEJMoa0908481. [DOI] [PubMed] [Google Scholar]
  • 16.Kumar A., Zarychanski R., Pinto R., Cook D.J., Marshall J., Lacroix J., Canadian Critical Care Trials Group H1N1 Collaborative Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA. 2009;302:1872–1879. doi: 10.1001/jama.2009.1496. [DOI] [PubMed] [Google Scholar]
  • 17.Rello J., Rodríguez A., Ibáñez P., Socias L., Cebrián J., Marques A., Guerrero J., H1N1 SEMICYUC Working Group Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain. Crit Care. 2009;13:R148. doi: 10.1186/cc8044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Díaz E., Martín-Loeches I., Canadell L., Vidaur L., Suárez D., Socias L., H1N1 SEMICYUC-CIBERES-REIPI Working Group (GETGAG) Corticosteroid therapy in patients with primary viral pneumonia due to pandemic (H1N1) 2009 influenza. J Infect. 2012;64:311–318. doi: 10.1016/j.jinf.2011.12.010. [DOI] [PubMed] [Google Scholar]
  • 19.Klugman K.P., Chien Y.W., Madhi S.A. Pneumococcal pneumonia and influenza: a deadly combination. Vaccine. 2009;27:C9–C14. doi: 10.1016/j.vaccine.2009.06.007. [DOI] [PubMed] [Google Scholar]
  • 20.Louria D.B., Blumenfeld H.L., Ellis J.T., Kilbourne E.D., Rogers D.E. Studies on influenza in the pandemic of 1957–1958. II. Pulmonary complications of influenza. J Clin Invest. 1959;38:213–265. doi: 10.1172/JCI103791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Oswald N.C., Shooter R.A., Curwen M.P. Pneumonia complicating Asian influenza. Br Med J. 1958;2:1305–1311. doi: 10.1136/bmj.2.5108.1305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Echevarría-Zuno S., Mejía-Aranguré J.M., Mar-Obeso A.J., Grajales-Muñiz C., Robles-Pérez E., González-León M. Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis. Lancet. 2009;374:2072–2079. doi: 10.1016/S0140-6736(09)61638-X. [DOI] [PubMed] [Google Scholar]
  • 23.Estenssoro E., Ríos F.G., Apezteguía C., Reina R., Neira J., Ceraso D.H. Pandemic 2009 influenza A in Argentina: a study of 337 patients on mechanical ventilation. Am J Respir Crit Care Med. 2010;182:41–48. doi: 10.1164/201001-0037OC. [DOI] [PubMed] [Google Scholar]
  • 24.Palacios G., Hornig M., Cisterna D., Savji N., Bussetti A.V., Kapoor V. Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza. PLoS One. 2009;4:e8540. doi: 10.1371/journal.pone.0008540. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Murray R.J., Robinson J.O., White J.N., Hughes F., Coombs G.W., Pearson J.C. Community-acquired pneumonia due to pandemic A(H1N1)2009 influenzavirus and methicillin resistant Staphylococcus aureus co-infection. PLoS One. 2010;5:e8705. doi: 10.1371/journal.pone.0008705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Garcia-Vidal C., Barba P., Arnan M., Moreno A., Ruiz-Camps I., Gudiol C. Invasive aspergillosis complicating pandemic influenza A (H1N1) infection in severely immunocompromised patients. Clin Infect Dis. 2011;53:e16–e19. doi: 10.1093/cid/cir485. [DOI] [PubMed] [Google Scholar]
  • 27.Jean C., Louie J.K., Glaser C.A., Harriman K., Hacker J.K., Aranki F. Invasive group A streptococcal infection concurrent with 2009 H1N1 influenza. Clin Infect Dis. 2010;50:e59–e62. doi: 10.1086/652291. [DOI] [PubMed] [Google Scholar]
  • 28.Dhanoa A., Fang N.C., Hassan S.S., Kaniappan P., Rajasekaram G. Epidemiology and clinical characteristics of hospitalized patients with pandemic influenza A (H1N1) 2009 infections: the effects of bacterial coinfection. Virol J. 2011;8:501. doi: 10.1186/1743-422X-8-501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Guervilly C., Coisel Y., Botelho-Nevers E., Dizier S., Castanier M., Lepaul-Ercole R. Significance of high levels of procalcitonin in patients with influenza A (H1N1) pneumonia. J Infect. 2010;61:355–358. doi: 10.1016/j.jinf.2010.07.013. [DOI] [PubMed] [Google Scholar]
  • 30.Ahn S., Kim W.Y., Kim S.H., Hong S., Lim C.M., Koh Y. Role of procalcitonin and C-reactive protein in differentiation of mixed bacterial infection from 2009 H1N1 viral pneumonia. Influenza Other Respi Viruses. 2011;5:398–403. doi: 10.1111/j.1750-2659.2011.00244.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Martín-Loeches I., Sánchez-Corral A., Díaz E., Granada R.M., Zaragoza R., Villavicencio C., H1N1 SEMICYUC Working Group Community-acquired respiratory coinfection in critically ill patients with pandemic 2009 influenza A(H1N1) virus. Chest. 2011;139:555–562. doi: 10.1378/chest.10-1396. [DOI] [PubMed] [Google Scholar]
  • 32.Abbo L., Quartin A., Morris M.I., Saigal G., Ariza-Heredia E., Mariani P. Pulmonary imaging of pandemic influenza H1N1 infection: relationship between clinical presentation and disease burden on chest radiography and CT. Br J Radiol. 2010;83:645–651. doi: 10.1259/bjr/53692814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Cunha B., Syed U., Strollo S. During the “herald wave” of the pandemic bacterial pneumonia relatively rare with fatal swine influenza (H1N1) pneumonia: if chest films have no focal segmental/lobar infiltrates, antibiotic therapy is unnecessary. J Chemother. 2009;21:584–589. doi: 10.1179/joc.2009.21.5.584. [DOI] [PubMed] [Google Scholar]
  • 34.Ko F.W., Ip M., Chan P.K., Fok J.P., Chan M.C., Ngai J.C. A 1-year prospective study of the infectious etiology in patients hospitalized with acute exacerbations of COPD. Chest. 2007;131:44–52. doi: 10.1378/chest.06-1355. [DOI] [PubMed] [Google Scholar]
  • 35.Rohde G., Wiethege A., Borg I., Kauth M., Bauer T.T., Gillissen A. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study. Thorax. 2003;58:37–42. doi: 10.1136/thorax.58.1.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Dawood F.S., Kamimoto L., D’Mello T.A., Reingold A., Gershman K., Meek J. Children with asthma hospitalized with seasonal or pandemic influenza, 2003–2009. Pediatrics. 2011;128:e27–e32. doi: 10.1542/peds.2010-3343. [DOI] [PubMed] [Google Scholar]
  • 37.Miller R.R., 3rd, Markewitz B.A., Rolfs R.T., Brown S.M., Dascomb K.K., Grissom C.K. Clinical findings and demographic factors associated with intensive care unit admission in Utah due to 2009 novel influenza A (H1N1) infection. Chest. 2010;137:752–758. doi: 10.1378/chest.09-2517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Verrall A., Norton K., Rooker S., Dee S., Olsen L., Tan C.E. Hospitalizations for pandemic (H1N1) 2009 among Maori and Pacific Islanders, New Zealand. Emerg Infect Dis. 2010;16:100–102. doi: 10.3201/eid1601.090994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Cullen G., Martin J., O’Donnell J., Boland M., Canny M., Keane E. Surveillance of the first 205 confirmed hospitalised cases of pandemic H1N1 influenza in Ireland, 28 April - 3 October 2009. Euro Surveill. 2009;14:19389. [PubMed] [Google Scholar]
  • 40.Viasus D., Paño-Pardo J.R., Pachón J., Campins A., López-Medrano F., Villoslada A. Factors associated with severe disease in hospitalized adults with pandemic (H1N1) 2009 in Spain. Clin Microbiol Infect. 2011;17:738–746. doi: 10.1111/j.1469-0691.2010.03362.x. [DOI] [PubMed] [Google Scholar]
  • 41.Paño-Pardo J.R., Rodríguez-Baño J., Martínez-Sánchez N., Viasus D., Fariñas M.C., Leyes M. Prognosis of 2009 A(H1N1) influenza in hospitalized pregnant women in a context of early diagnosis and antiviral therapy. Antivir Ther. 2011 doi: 10.3851/IMP2019. doi: 10. 3851/IMP2019. [DOI] [PubMed] [Google Scholar]
  • 42.Riera M., Payeras A., Marcos M.A., Viasus D., Fariñas M.C., Segura F. Clinical presentation and prognosis of the 2009 H1N1 influenza A infection in HIV-1-infected patients: a Spanish multicenter study. AIDS. 2010;24:2461–2467. doi: 10.1097/QAD.0b013e32833e508f. [DOI] [PubMed] [Google Scholar]
  • 43.Han K., Ma H., An X., Su Y., Chen J., Lian Z. Early use of glucocorticoids was a risk factor for critical disease and death from pH1N1 infection. Clin Infect Dis. 2011;53:326–333. doi: 10.1093/cid/cir398. [DOI] [PubMed] [Google Scholar]
  • 44.Van Kerkhove M.D., Vandemaele K.A., Shinde V., Jaramillo-Gutierrez G., Koukounari A., Donnelly C.A. Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS Med. 2011;8:e1001053. doi: 10.1371/journal.pmed.1001053. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Gilca R., De Serres G., Boulianne N., Ouhoummane N., Papenburg J., Douville-Fradet M. Risk factors for hospitalization and severe outcomes of 2009 pandemic H1N1 influenza in Quebec, Canada. Influenza Other Respi Viruses. 2011;5:247–255. doi: 10.1111/j.1750-2659.2011.00204.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Viasus D., Paño-Pardo J.R., Pachón J., Riera M., López-Medrano F., Payeras A. Timing of oseltamivir administration and outcomes in hospitalized adults with pandemic 2009 influenza A(H1N1) virus infection. Chest. 2011;140:1025–1032. doi: 10.1378/chest.10-2792. [DOI] [PubMed] [Google Scholar]
  • 47.Brandão-Neto R.A., Goulart A.C., Santana A.N., Martins H.S., Ribeiro S.C., Ho L.Y. The role of pneumonia scores in the emergency room in patients infected by 2009 H1N1 infection. Eur J Emerg Med. 2012;19:200–202. doi: 10.1097/MEJ.0b013e328349ed85. [DOI] [PubMed] [Google Scholar]
  • 48.Pereira J.M., Moreno R.P., Matos R., Rhodes A., Martin-Loeches I., Cecconi M. Severity assessment tools in ICU patients with 2009 Influenza A (H1N1) pneumonia. Clin Microbiol Infect. 2012;18:1040–1048. doi: 10.1111/j.1469-0691.2011.03736.x. [DOI] [PubMed] [Google Scholar]
  • 49.Warren-Gash C., Smeeth L., Hayward A.C. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis. 2009;9:601–610. doi: 10.1016/S1473-3099(09)70233-6. [DOI] [PubMed] [Google Scholar]
  • 50.Erden I., Erden E.C., Ozhan H., Basar C. Acute myocarditis mimicking acute myocardial infarction associated with pandemic 2009 (H1N1) influenza A virus. Cardiol J. 2011;18:552–555. [PubMed] [Google Scholar]
  • 51.Chacko B., Peter J.V., Pichamuthu K., Ramakrishna K., Moorthy M., Karthik R. Cardiac manifestations in patients with pandemic (H1N1) 2009 virus infection needing intensive care. J Crit Care. 2012;27:106.e1–106.e6. doi: 10.1016/j.jcrc.2011.05.016. [DOI] [PubMed] [Google Scholar]
  • 52.Akritidis N., Mastora M., Baxevanos G., Dimos G., Pappas G. Electrocardiographic abnormalities in patients with novel H1N1 influenza virus infection. Am J Cardiol. 2010;106:1517–1519. doi: 10.1016/j.amjcard.2010.06.078. [DOI] [PubMed] [Google Scholar]
  • 53.Kedia S., Stroud B., Parsons J., Schreiner T., Curtis D.J., Bagdure D. Pediatric neurological complications of 2009 pandemic influenza A (H1N1) Arch Neurol. 2011;68:455–462. doi: 10.1001/archneurol.2010.318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Glaser C., Winter K., Dubray K., Harriman K., Uyeki T.M., Sejvar J. A Population- Based Study of Neurologic Manifestations of Severe Influenza A(H1N1)pdm09 in California. Clin Infect Dis. 2012;55:514–520. doi: 10.1093/cid/cis454. [DOI] [PubMed] [Google Scholar]
  • 55.Lewis D.E., Gilbert B.E., Knight V. Influenza virus infection induces functional alterations in peripheral blood lymphocytes. J Immunol. 1986;137:3777–3781. [PubMed] [Google Scholar]
  • 56.Viasus D., Paño-Pardo J.R., Cordero E., Campins A., López-Medrano F., Villoslada A. Effect of immunomodulatory therapies in patients with pandemic influenza A (H1N1) 2009 complicated by pneumonia. J Infect. 2011;62:193–199. doi: 10.1016/j.jinf.2011.01.014. [DOI] [PubMed] [Google Scholar]
  • 57.Fujii T., Nakamura T., Iwamoto A. Current concepts in SARS treatment. J Infect Chemother. 2004;10:1–7. doi: 10.1007/s10156-003-0296-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Demirjian S.G., Raina R., Bhimraj A., Navaneethan S.D., Gordon S.M., Schreiber M.J., Jr. 2009 influenza A infection and acute kidney injury: incidence, risk factors, and complications. Am J Nephrol. 2011;34:1–8. doi: 10.1159/000328386. [DOI] [PubMed] [Google Scholar]

Articles from Enfermedades Infecciosas Y Microbiologia Clinica are provided here courtesy of Elsevier

RESOURCES